Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050
Opinion
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
ONCOLife
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
AI in Life Sciences: Trends and Predictions for 2025 - By Doron Sitbon
AI
The Internet of Medical Things needs a new security model to fulfil its potential
Digital Health
Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions
Can Artificial Intelligence Help Bridge the Gap in Healthcare Tech Skills?
AI and VR – two little acronyms that will change the healthcare world this year
Deloitte's Survey Uncovers Optimism and Concerns in Generative AI Adoption
Beyond SEP-1: Evolving Strategies in Sepsis Care and CMS Reimbursement Policies
How a service design approach can make digital hospitals a reality?
Subscribe for the latest news and events
Most Popular
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
